Ultragenyx Pharmaceutical | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Insmed USD 52.01M 9.7M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
Kyowa Hakko Kirin JPY 157.02B 16.2B 2024-12
MacroGenics USD 8.75M 2.56M 2024-09
Moderna USD 592M 1.24B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Ultragenyx Pharmaceutical Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.